AAAAAA
Results:
1-22
|
Results: 22
Authors:
Ramachandran, C
Melnick, SJ
Escalon, E
Khatib, Z
Jhabvala, P
Fonseca, HB
Smith, S
Alamo, A
Medina, S
Citation: C. Ramachandran et al., Cytogenetic and molecular characterization of a congenital mesoblastic nephroma, PEDIATR D P, 4(4), 2001, pp. 402-411
Authors:
Wu, HL
Ramachandran, C
Bielinska, AU
Kingzett, K
Sun, R
Weiner, ND
Roessler, BJ
Citation: Hl. Wu et al., Topical transfection using plasmid DNA in a water-in-oil nanoemulsion, INT J PHARM, 221(1-2), 2001, pp. 23-34
Authors:
Wu, HL
Ramachandran, C
Weiner, ND
Roessler, BJ
Citation: Hl. Wu et al., Topical transport of hydrophilic compounds using water-in-oil nanoemulsions, INT J PHARM, 220(1-2), 2001, pp. 63-75
Authors:
Asante-Appiah, E
Ball, K
Bateman, K
Skorey, K
Friesen, R
Desponts, C
Payette, P
Bayly, C
Zamboni, R
Scapin, G
Ramachandran, C
Kennedy, BP
Citation: E. Asante-appiah et al., The YRD motif is a major determinant of substrate and inhibitor specificity in T-cell protein-tyrosine phosphatase, J BIOL CHEM, 276(28), 2001, pp. 26036-26043
Authors:
Skorey, KI
Kennedy, BP
Friesen, RW
Ramachandran, C
Citation: Ki. Skorey et al., Development of a robust scintillation proximity assay for protein tyrosinephosphatase 1B using the catalytically inactive (C215S) mutant, ANALYT BIOC, 291(2), 2001, pp. 269-278
Authors:
Ramachandran, C
Melnick, SJ
Escalon, E
Jhabvala, P
Khatib, Z
Alamo, A
Smith, S
Citation: C. Ramachandran et al., Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors, ANTICANC R, 20(5C), 2000, pp. 3759-3765
Authors:
Ducret, A
Desponts, C
Desmarais, S
Gresser, MJ
Ramachandran, C
Citation: A. Ducret et al., A general method for the rapid characterization of tyrosine-phosphorylatedproteins by mini two-dimensional gel electrophoresis, ELECTROPHOR, 21(11), 2000, pp. 2196-2208
Authors:
Ramachandran, C
Fleisher, D
Citation: C. Ramachandran et D. Fleisher, Transdermal delivery of drugs for the treatment of bone diseases, ADV DRUG DE, 42(3), 2000, pp. 197-223
Authors:
Kennedy, BP
Ramachandran, C
Citation: Bp. Kennedy et C. Ramachandran, Protein tyrosine phosphatase-1B in diabetes, BIOCH PHARM, 60(7), 2000, pp. 877-883
Authors:
Waddleton, D
Ramachandran, C
Wang, QP
Citation: D. Waddleton et al., Development of a method for evaluating protein tyrosine phosphatase CD45 inhibitors using Jurkat cell membrane, ANALYT BIOC, 285(1), 2000, pp. 58-63
Authors:
Huang, Z
Wang, QP
Ly, HD
Gorvindarajan, A
Scheigetz, J
Zamboni, R
Desmarais, S
Ramachandran, C
Citation: Z. Huang et al., 3,4-fluorescein diphosphate: A sensitive fluorogenic and chromogenic substrate for protein tyrosine phosphatases, J BIOMOL SC, 4(6), 1999, pp. 327-334
Authors:
Ramachandran, C
Melnick, SJ
Citation: C. Ramachandran et Sj. Melnick, Multidrug resistance review in human tumors - Molecular diagnosis and clinical significance, MOL DIAGN, 4(2), 1999, pp. 81-94
Authors:
Cuncic, C
Detich, N
Ethier, D
Tracey, AS
Gresser, MJ
Ramachandran, C
Citation: C. Cuncic et al., Vanadate inhibition of protein tyrosine phosphatases in Jurkat cells: modulation by redox state, J BIOL I CH, 4(3), 1999, pp. 354-359
Authors:
Waranuch, N
Ramachandran, C
Weiner, ND
Citation: N. Waranuch et al., The influence of metabolism on percutaneous absorption of cyclosporin-A, J LIPOS RES, 9(1), 1999, pp. 129-138
Authors:
Waranuch, N
Ramachandran, C
Weiner, ND
Citation: N. Waranuch et al., Controlled topical delivery of hydrocortisone and mannitol via select pathways, J LIPOS RES, 9(1), 1999, pp. 139-153
Authors:
Desmarais, S
Friesen, RW
Zamboni, R
Ramachandran, C
Citation: S. Desmarais et al., [Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases, BIOCHEM J, 337, 1999, pp. 219-223
Authors:
Ramachandran, C
You, W
Citation: C. Ramachandran et W. You, Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin, BREAST CANC, 54(3), 1999, pp. 269-278
Authors:
Wang, QP
Scheigetz, J
Gilbert, M
Snider, J
Ramachandran, C
Citation: Qp. Wang et al., Fluorescein monophosphates as fluorogenic substrates for protein tyrosine phosphatases, BBA-PROT ST, 1431(1), 1999, pp. 14-23
Authors:
Elchebly, M
Payette, P
Michaliszyn, E
Cromlish, W
Collins, S
Loy, AL
Normandin, D
Cheng, A
Himms-Hagen, J
Chan, CC
Ramachandran, C
Gresser, MJ
Tremblay, ML
Kennedy, BP
Citation: M. Elchebly et al., Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene, SCIENCE, 283(5407), 1999, pp. 1544-1548
Authors:
Cuncic, C
Desmarais, S
Detich, N
Tracey, AS
Gresser, MJ
Ramachandran, C
Citation: C. Cuncic et al., Bis(N,N-dimethylhydroxamido)hydroxooxovanadate inhibition of protein tyrosine phosphatase activity in intact cells - Comparison with vanadate, BIOCH PHARM, 58(12), 1999, pp. 1859-1867
Authors:
Gamble, TN
Ramachandran, C
Bateman, KP
Citation: Tn. Gamble et al., Phosphopeptide isomer separation using capillary zone electrophoresis for the study of protein kinases and phosphatases, ANALYT CHEM, 71(16), 1999, pp. 3469-3476
Authors:
Taylor, SD
Kotoris, CC
Dinaut, AN
Wang, QP
Ramachandran, C
Huang, Z
Citation: Sd. Taylor et al., Potent non-peptidyl inhibitors of protein tyrosine phosphatase 1B (vol 6, pg 1457, 1998), BIO MED CH, 6(11), 1998, pp. 2235-2235
Risultati:
1-22
|